NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
Clinical Trials
13 trialsNCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
NCT07267247 2025-12-05
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
Completed
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT04790266 2025-11-18
CARDIOTOX
Oncology Institute of Southern Switzerland
Completed
NCT04036032 2025-10-14
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed